Please login to the form below

Not currently logged in

People, June, 2009

Recent high-profile moves in the pharmaceutical and healthcare industriesMover of the month is Greg Simon who has joined Pfizer as senior vice president

Mover of the month

Greg Simon - Senior vice president at Pfizer 

Greg Simon has joined Pfizer as senior vice president, worldwide policy. He joins from FasterCures, where he led efforts to reform policies governing biopharmaceutical discovery and development. He will be responsible for counsel and action on healthcare, science and technology policy issues. Mr Simon was chief domestic policy advisor to American Vice President, Al Gore, from 1993 to 1997. He oversaw programmes at the National Institutes of Health, the National Cancer Institute, the Food and Drug Administration and the Human Genome Project. Greg served as Senator Gore's legislative director from 1991 to 1993. He received his law degree from the University of Washington in 1983 and has a BA in history from the University of Arkansas.


Rachel Cummings is the new health policy and advocacy manager in the UK corporate affairs department at Napp Pharmaceuticals. During her 12-year career in healthcare, Rachel has held senior positions across global healthcare communications, medical education and publishing. She will work on corporate PR initiatives, partnership working, advocacy relations and health policy initiatives across Napp's chronic pain, oncology and respiratory portfolios. Rachel joins from Racepoint Group and previously held positions at Chandler Chicco Agency, Burson-Marsteller and Medicom.

Rachel Cummings - Napp Pharmaceuticals

Atul Sobti - Ranbaxy

Ranbaxy has made chief operating officer Atul Sobti CEO and Tsutomu Une chairman following the shock resignation of Malvinder Singh as CEO and chairman of the board four years ahead of schedule. Tsutomu Une was previously a non-executive director of Ranbaxy. Executives had insisted Malvinder Singh would be staying at the helm when he sold a controlling stake to the Japanese pharmaceutical company Daiichi Sankyo in June 2008.
Adventis Health has added three new account executives to its growing medical communications division: Sarah Gipps, Richard Irving and Zhizhi Chen

Sarah, Richard and Zhizhi - Adventis Health

Marianne Lynch - Life Healthcare Communications Claire Cornell - Life Healthcare Communications Sarah Young - Life Healthcare Communications Alison Hamilton - Life Healthcare Communications

Life Healthcare Communications has strengthened its creative team with the addition of Marianne Lynch as designer. Marianne is a New Zealander by birth and has worked for a number of London agencies. Sarah Young has also been promoted to head of copy. On the account side, Claire Cornell has been appointed as account executive. Claire has two years of client services experience in healthcare communications and PR and will be supporting the account team across a variety of accounts. Alison Hamilton has returned to the agency following maternity leave.

The Virgo HEALTH team has been boosted with the arrival of a new account director, Daniel Burges, new account manager Arash Khurana and five internal promotions: Hannah O'Neill, Rebecca McClure, Chiara Marcelline, Emily Brooks and Natasha Gifford. Daniel Burges joins from Munro & Forster. He has nine years of pharmaceutical communications experience. Arash Khurana joins from Porter Novelli - New York, bringing five years of experience co-managing communications campaigns. Hannah O'Neill has been promoted to associate director, Rebecca McClure and Chiara Marcelline are now account directors and Emily Brooks and Natasha Gifford have been promoted to senior account managers.
The Virgo Health team

Novartis has announced that Jonathan Symonds, former chief financial officer (CFO) at AstraZeneca and current MD of investment banking at Goldman Sachs, will join the Swiss group as deputy CFO and CFO designate. Symonds will join Novartis on September 1 and will report to current CFO, Raymond Breu, who retires on March 31, 2010. Symonds has been MD of investment banking Goldman Sachs since leaving AstraZeneca in 2007. During his eight years at AstraZeneca, he oversaw the original merger between Astra and Zeneca, as well as the acquisitions of several other companies.

Dr Thomas Werner has been appointed to the board of SkyePharma as non-executive director. Dr Werner has over 26 years' experience in the pharmaceutical industry, most recently as managing director and senior vice-president of GlaxoSmithKline Germany. Prior to that, he held senior positions at GlaxoWellcome Germany, Bristol-Myers Squibb Germany and Convatec Germany, (a medical devices subsidiary of Bristol-Myers Squibb). Dr Werner sits on the board of trustees of both the Paul Ehrlich Association and the Robert Koch Foundation. Dr Argeris (Jerry) Karabelas stood down from the board following the annual general meeting in May.

Dr Suhail Nurbhai has been made chief medical officer at PregLem. He has over 15 years' experience in clinical research and development in the pharmaceutical industry and spent 12 years at Pfizer developing multiple GU/sexual health medicines. Dr Nurbhai then joined Dynogen Pharmaceuticals as vice president and head of clinical development. He is a member of the Royal College of Physicians.
Liberation has hired Lolita McGee and Vidya Worden as consultants. Lolita joins from Athena Medical PR where she was a senior account manager. Prior to this, she was on Servier's marketing team for Protelos. Vidya has worked for a number of communications agencies and has been a communications manager at Boehringer Ingelheim.

Jane Smith has been appointed as managing director of Medicus International, part of the Publicis Healthcare Communications Group. Previously, Jane was managing director of Medicus International's sister company, Discovery London, and prior to that, director of client services at Medicus International.

Brand Attention has appointed Scott Heyhoe as sales and marketing director. He has over 20 years' experience in business development, having previously held senior positions at T-Mobile and Vodafone. Brand Attention's clients include BUPA, the NHS and Roche.

Photosound, a HealthSTAR Company, has appointed Tobias Maass as a technical installations assistant within the IT and technical installations team. A graduate from the University of Westminster, Tobias joins Photosound from a business and technology apprenticeship in Germany. Grace Clutton also joins the company as a project co-ordinator within the global client services team. A graduate in media communications, Grace joins from CCD Conference Reservations.

Cassandra Rix has been promoted to principal consultant at Red Kite consulting group. She has worked in the healthcare environment since 1995, holding positions in purchasing, sales, product development and management. She specialises in the health service, specialising in NHS relationship development and integrated care.

Two appointments have been made at Abacus International. A specialist in evidence-based medicine (EBM), Jodie Barden joins as a project manager in the systematic review team, while Ruth McAllister, formerly technical lead at the National Institute for Health and Clinical Excellence (NICE), joins as a consultant health economist. Jodie has experience of delivering systematic literature reviews and meta-analyses in academic and commercial environments. Following study at Oxford University and the Bandolier research group, she spent three years as an EBM manager at Pfizer UK and more recently worked as a director of EBM and health technology assessment in Pfizer's global team. With over five years' experience in health outcomes research, Ruth has knowledge of both health technology appraisals and clinical guidelines. She was involved in the recent update of methods for technology assessments at NICE and brings best-practice knowledge of health economic evaluations.

Obituary - Martin Symons

Martin Symons

After graduating in modern languages, Martin became a salesman in the chemicals division of ICI. He then transferred to ICI Pharmaceuticals, where he worked with their subsidiary in Italy and their Greek distributor, before spending two years with ICI Holland. A stint in corporate business development was followed by a move to international strategic marketing, with responsibility for ICI's CNS portfolio. Martin then spent time in the US developing and implementing a post-patent expiry strategy for a major CNS product before he moved to Italy as sales and marketing director, then as business development director. In 1999, Martin left ICI/Zeneca and joined Quintiles/Innovex as general manager in Italy. In 2005, he joined the Recordati Group to set up the UK subsidiary, which launched in March 2006. He was general manager of the company and, from the start, his energy and inspiration set the tone. Martin's great contribution was in gaining a full understanding of the NHS and moulding the business into one that treated it as a single customer with one rep responsible for all the interfaces with all customers on their patch. Martin was compassionate with staff. Always empathic and caring, he set an example that everybody strove to emulate. He worked tirelessly to make Recordati Pharmaceuticals a company that people wanted to work for and make a success. Martin had a passion for key account management, which he extolled and shared across the industry. All who met him were charmed by his openness, enthusiasm and interest in people and their ideas. Martin was much loved and will be missed by all who knew him.

Related links

FAQ: How do I get my move listed


Subscribe to our email news alerts

Featured jobs


Add my company
Oxford University Press

Oxford University Press publishes over 100 prestigious, highly cited, and authoritative medical journals, many in collaboration with some of the...

Latest intelligence

Pharma’s vital role in sustainability and corporate social responsibility
Pharma is in the spotlight as tough questions about sustainability commitments continue to arise...
Infographic: Therapy Watch Hyperlipidaemia
Our latest infographic offers an introduction to the real-world insights collected by our Hyperlipidaemia study....
Article: The rise of the healthcare influencer
In our latest article for Pharmaphorum Deep Dive, we explore the opportunities and benefits for healthcare companies in the online influencer space....